/PRNewswire/ Biosyngen, an immune-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma treatment, today announced.
New state-of-the-art facility to develop immunotherapy assets to address unmet needs in cancer treatmentSINGAPORE - Media OutReach - 28 June 2023 – Biosyngen, an.
GUANGZHOU, China, Dec. 29, 2021 /PRNewswire/ The inauguration ceremony of Biosyngen Pte. Ltd., ("Biosyngen") joint projects and Biosyngen biological production base was held in China-Singapore Guangzhou Knowledge City (CSGKC), on December 28th , 2021. Representatives from both countries celebrated the landmark achievement Government officials from Guangzhou Huangpu District and development district, General-Consulate of the Republic of Singapore.